Page last updated: 2024-09-05

1,4,7-triazacyclononane and beta-thujaplicin

1,4,7-triazacyclononane has been researched along with beta-thujaplicin in 1 studies

Compound Research Comparison

Studies
(1,4,7-triazacyclononane)
Trials
(1,4,7-triazacyclononane)
Recent Studies (post-2010)
(1,4,7-triazacyclononane)
Studies
(beta-thujaplicin)
Trials
(beta-thujaplicin)
Recent Studies (post-2010) (beta-thujaplicin)
76039205399

Protein Interaction Comparison

ProteinTaxonomy1,4,7-triazacyclononane (IC50)beta-thujaplicin (IC50)
E3 ubiquitin-protein ligase Mdm2 isoform aHomo sapiens (human)3.58
protein Mdm4 isoform 1Homo sapiens (human)3.58
Polyphenol oxidase 2Agaricus bisporus0.09
Carboxypeptidase A1Bos taurus (cattle)2.76
TyrosinaseHomo sapiens (human)8.98
Breast cancer type 1 susceptibility proteinHomo sapiens (human)3.89
BRCA1-associated RING domain protein 1Homo sapiens (human)3.89

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT1

Other Studies

1 other study(ies) available for 1,4,7-triazacyclononane and beta-thujaplicin

ArticleYear
Identifying chelators for metalloprotein inhibitors using a fragment-based approach.
    Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

    Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011